Sources | Names Used |
---|---|
CTRPv2 | selumetinib:decitabine (4:1 mol/mol) |
PharmacoGx | selumetinib:decitabine (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GMPPB | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
mRNA | DDB2 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | CYP3A5 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | UHRF1BP1L | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
mRNA | GRIP2 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | TRAF3IP2 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | CYP3A7-CYP3A51P | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | GJC2 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
mRNA | NET1 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | TMEM263 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |